The human genome was sequenced – or read in its entirety – for the first time in 2003, after more than 20 years of work.
In the ensuing decades, genetic information catapulted into mainstream healthcare driven largely by the rapid decline in cost for DNA sequencing technology.
Today, there is a massive opportunity for genetic testing firms to help healthcare organizations use DNA to steer more personalized treatments.
In “Key Players in Genetic Testing,” Insider Intelligence gives an overview of the four genetic testing companies – 23andMe, Ancestry, Color, and Invitae – that are racing to the forefront of healthcare.
Simply enter your information to get a copy of this exclusive PDF and to start receiving our Chart of the Day newsletter, which delivers data and key statistics on the top trends in today’s most disruptive industries.